The Company develops and manufactures minimally invasive visual implants and other ophthalmic products to improve or correct the vision of patients with cataracts and refractive conditions and distributes them worldwide.
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ratings and Key Statistics provided by Zacks.
SEC Filings and Insider Transactions provided by Edgar Online.
Powered and implemented by Interactive Data Managed Solutions. Terms & Conditions
RSS Headlines
Fool UK
Recs
its already out performing S&P 500
This stock should double today after the opening.
bought for a buck and a half and today I find out they are set to get FDA approval for their newest procedure.. This stock should really jump, especially if they become someones buyout candidate.
RUMORS OF A BUYOUT